Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

GlycoMimetics Company Profile (NASDAQ:GLYC)

Consensus Ratings for GlycoMimetics (NASDAQ:GLYC) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $13.33 (61.23% upside)

Analysts' Ratings History for GlycoMimetics (NASDAQ:GLYC)
Show:
DateFirmActionRatingPrice TargetActions
5/6/2015Jefferies GroupReiterated RatingBuy -> Buy$18.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/7/2015Canaccord GenuitySet Price TargetBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2015Stifel NicolausBoost Price TargetBuy$13.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/25/2015Canaccord GenuityReiterated RatingBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/15/2014Stifel NicolausBoost Price TargetBuy$14.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2014Jefferies GroupBoost Price Target$13.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2014BarclaysInitiated CoverageOverweight$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2014Canaccord GenuityInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2014Stifel NicolausInitiated CoverageBuy$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2014Jefferies GroupInitiated CoverageBuy$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2013 forward)